NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

"The only question left for me is whether or not all improvements to L have been included in this trial."

I was thinking exactly that just 2 minutes before reading your post. There is so much generally to be learned when the data is unblinded...

Maybe even information useful for Direct, but certainly for the DCVax-L / CI combo trial.

Even if they don't learn anything useful for the next trial, it wouldn't make much sense to not take a good look before pulling the trigger on any new trial protocols. Yet they claim to have already worked out a trial design for the L + CI trial... . But that might not be in stone quite yet.